Figure 2From: Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ HybridizationDisease-specific survival curves according to miR-155 expression in: (A) the total material; (B) squamous cell carcinomas (SCCs); (C) adenocarcinomas (ACs).Back to article page